1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. - Wikidata - wikimedia - TriplyDB

1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases.

1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases.

http://www.wikidata.org/entity/Q37369232

about

The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer Human urinary exosomes as innate immune effectors.Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation.Nutritionally-induced catch-up growth Vitamin d and susceptibility of chronic lung diseases: role of epigenetics.Vitamin D enhances corneal epithelial barrier function Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act.ERp57/GRP58: a protein with multiple functions.Vitamin D: metabolism, molecular mechanisms, and mutations to malignancies.How long bones grow children: Mechanistic paths to variation in human height growth.Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.Analysis of the interaction of calcitriol with the disulfide isomerase ERp57.Terminal differentiation of chick embryo chondrocytes requires shedding of a cell surface protein that binds 1,25-dihydroxyvitamin D3.Vitamin D Replacement Improves Tear Osmolarity in Patients with Vitamin D Deficiency.GnRH immunization alters the expression and distribution of protein disulfide isomerases in the epididymis.MicroRNA Contents in Matrix Vesicles Produced by Growth Plate Chondrocytes are Cell Maturation Dependent.

P2860

Q24625481-CD87924C-9DA3-4C4D-A97C-CA042ADA77E1 Q34103485-7D64D1A4-8C60-4FBC-91B8-ADBF3333FFC8 Q34629145-7F7ED37D-FFE4-46C4-8331-65FECA0B6A71 Q35003838-A1E1A796-381B-4A77-8B1F-FCC373BDFEEF Q35208296-6DF5206C-96A8-4FDA-8A46-89B48C3FA19C Q35247612-52D99229-C61F-4439-9ACE-1AA8C08C7170 Q37375714-6BF5B7B2-5CB3-4534-9987-AF552401097E Q37916360-9B6B074D-EC89-4371-A345-503E03FE8B38 Q38077504-079BD2C6-0FAC-4A30-AFCC-F8B01A0D7CA2 Q39144038-5AAB1BC8-D4DB-4B99-9EF3-6CE6F88372BC Q39445097-CED04B4B-9B52-402D-A192-398C05180225 Q42362394-39445902-FAE4-439D-9D35-6D576A7AD5A8 Q46913673-5CA936DE-A9A3-4D97-93B9-7C2AE2F7CEC9 Q48027974-21D8FE4C-C44C-463D-BFA3-B4B539A25E14 Q48193398-925657FB-B258-4D18-AAFA-565298A15065 Q55023441-52070936-DCF4-4607-9202-00A53484B664

P2860

1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases.

http://www.wikidata.org/entity/Q37369232

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 January 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

1alpha,25(OH)2D3 is an autocri ...... ix vesicle metalloproteinases.

@en

1alpha,25(OH)2D3 is an autocri ...... ix vesicle metalloproteinases.

@nl

type

label

1alpha,25(OH)2D3 is an autocri ...... ix vesicle metalloproteinases.

@en

1alpha,25(OH)2D3 is an autocri ...... ix vesicle metalloproteinases.

@nl

prefLabel

1alpha,25(OH)2D3 is an autocri ...... ix vesicle metalloproteinases.

@en

1alpha,25(OH)2D3 is an autocri ...... ix vesicle metalloproteinases.

@nl

P1433

Q37369232-5C86B51B-EDA4-4BB1-8AFF-FB7940308216

P1476

Q37369232-F35E3586-CCAD-4618-BFC2-44716A32DBD6

P2093

Q37369232-19DE73EE-3127-4DB3-A163-FA991F094699

Q37369232-286A90D1-53AE-46AF-A911-31A087CF0134

Q37369232-36F925AA-A579-4AAE-AF78-3958401298C8

Q37369232-B5AA4E5F-B86B-4D57-956E-DB4EC6BF4F3C

P2860

Q37369232-07E0FE85-1654-44A2-BDF9-E8A9D38012CF

Q37369232-08C061A2-EA5A-4D04-9929-8D277591F678

Q37369232-0ED82067-645D-4259-A3E9-0106A4A490A9

Q37369232-2EC56AE9-8770-4BEF-9086-106E7A0FDB41

Q37369232-4A2C02EE-C736-446F-A04A-DCFB84CE358C

Q37369232-56BC21B5-BABB-4626-8A24-CF405BCD95A6

Q37369232-5CD5CE9D-0E40-4ADA-8091-D089D0B39B60

Q37369232-5DF3719D-B247-4439-95A5-E199DCB3F7C9

Q37369232-6002430E-C184-4362-BDD1-38FE63CD25AA

Q37369232-6CCAFE01-98EE-4D8B-B8B4-AE59BCBE9094

P304

Q37369232-3F4F808B-C19D-45EF-AB70-28AD08D70151

P31

Q37369232-9F8CD5D6-74F9-4A10-B79B-91C114FC33F7

P356

Q37369232-FC732599-5FBF-4B9D-B85A-C0E94EDA1349

P433

Q37369232-471E8A23-50C9-47E1-B53A-D86EBDBBCA58

P478

Q37369232-1D40B543-3D23-4F92-B3BF-26830CFEFD50

P577

Q37369232-1C4A6E02-8B4A-48BF-9A09-7B97B58BD685

P5875

Q37369232-232B13F2-C601-4226-BFF2-5F37D1284004

P698

Q37369232-CF22E4DF-EB6B-46D6-909B-24A589B737FD

P921

Q37369232-BD85BBBE-7EFE-4F90-B5FE-A066C5C19F5D

P932

Q37369232-51D43D63-0B49-4B5D-9EEA-6D2FC1DEE7DB

P356

J.JSBMB.2006.11.003

P1433

The Journal of Steroid Biochemistry and Molecular Biology

P1476

1alpha,25(OH)2D3 is an autocri ...... ix vesicle metalloproteinases.

@en

P2093

Barbara D Boyan

http://www.w3.org/2001/XMLSchema#string

Kevin L Wong

http://www.w3.org/2001/XMLSchema#string

Mimi Fang

http://www.w3.org/2001/XMLSchema#string

Zvi Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3)

Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes

Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells.

Mechanisms regulating differential activation of membrane-mediated signaling by 1alpha,25(OH)2D3 and 24R,25(OH)2D3.

Rapid vitamin D-dependent PKC signaling shares features with estrogen-dependent PKC signaling in cartilage and bone.

Regulation of phospholipase D (PLD) in growth plate chondrocytes by 24R,25-(OH)2D3 is dependent on cell maturation state (resting zone cells) and is specific to the PLD2 isoform.

Molecular mechanisms of PKCalpha localization and activation by arachidonic acid. The C2 domain also plays a role.

Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3.

Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes.

24,25-(OH)2D3 regulation of matrix vesicle protein kinase C occurs both during biosynthesis and in the extracellular matrix.

P304

467-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSBMB.2006.11.003

http://www.w3.org/2001/XMLSchema#string

P433

3-5

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6578517

http://www.w3.org/2001/XMLSchema#string

P698

17224270

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

P932

2754708

http://www.w3.org/2001/XMLSchema#string